Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 3-nitro-2-pyrrol-1-ylbenzoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1448531-52-9

Post Buying Request

1448531-52-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1448531-52-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1448531-52-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,8,5,3 and 1 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1448531-52:
(9*1)+(8*4)+(7*4)+(6*8)+(5*5)+(4*3)+(3*1)+(2*5)+(1*2)=169
169 % 10 = 9
So 1448531-52-9 is a valid CAS Registry Number.

1448531-52-9Relevant academic research and scientific papers

Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells

Desplat, Vanessa,Vincenzi, Marian,Lucas, Romain,Moreau, Stéphane,Savrimoutou, Solène,Rubio, Sandra,Pinaud, No?l,Bigat, David,Enriquez, Elodie,Marchivie, Mathieu,Routier, Sylvain,Sonnet, Pascal,Rossi, Filomena,Ronga, Luisa,Guillon, Jean

, p. 940 - 953 (2017/06/27)

Acute leukemia is a hematological malignancy with high incidence and recurrence rates and is characterized by an accumulation of blasts in bone marrow due to proliferation of immature lymphoid or myeloid cells associated with a blockade of differentiation. The heterogeneity of leukemia led us to look for new specific molecules for leukemia subtypes or for therapy-resistant cases. Among heterocyclic derivatives that attracted attention due to their wide range of biological activities, we focused our interest on the pyrrolo[1,2-a]quinoxaline heterocyclic framework that has been previously identified as an interesting scaffold for antiproliferative activities against various human cancer cell lines. In this work, new ethyl 4-[4-(4-substituted piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate derivatives (1 a–o) were designed, synthesized, and evaluated against five different leukemia cell lines, including Jurkat and U266 (lymphoid cell lines) and K562, U937, and HL60 (myeloid cell lines), as well as on normal human peripheral blood mononuclear cells (PBMCs). This new pyrrolo[1,2-a]quinoxaline series showed interesting cytotoxic potential against all tested leukemia cell lines. In particular, pyrroloquinoxalines 1 a and 1 m,n seem to be interesting due to their high activity against leukemia and their low activity against normal hematopoietic cells, leading to a high index of selectivity.

Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a] quinoxaline derivatives as inhibitors of the human protein kinase CK2

Guillon, Jean,Le Borgne, Marc,Rimbault, Charlotte,Moreau, Stéphane,Savrimoutou, Solène,Pinaud, No?l,Baratin, Sophie,Marchivie, Mathieu,Roche, Séverine,Bollacke, Andre,Pecci, Adali,Alvarez, Lautaro,Desplat, Vanessa,Jose, Joachim

, p. 205 - 222 (2013/10/01)

Herein we describe the synthesis and properties of substituted phenylaminopyrrolo[1,2-a]quinoxaline-carboxylic acid derivatives as a novel class of potent inhibitors of the human protein kinase CK2. A set of 15 compounds was designed and synthesized using

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1448531-52-9